Consequences of identification and notification
In accordance with the procedure laid down in Article 28(3) of the Directive, a Regulation shall be adopted containing:
an exhaustive list of existing active substances placed on the market for use in biocidal products, for which substances at least one identification complies with the requirements of Article 3(1) or Article 5(2) or equivalent information submitted in a notification according to Article 4(1); and
an exhaustive list of existing active substances to be reviewed during the second phase of the review programme containing those existing active substances
for which the Commission has accepted at least one notification in accordance with Article 4(1) or Article 8(1); or
that Member States have indicated in accordance with Article 5(3); or
for which, following indications in accordance with Article 8(3) or (4), Member States, alone or collectively, have agreed to provide the necessary data to carry out evaluations for possible inclusion in Annex IB to the Directive in the second phase of the review programme.
The Commission shall make the lists publicly available by electronic means.
Without prejudice to Article 16(1), (2) or (3) of the Directive, all producers of an active substance included in the list referred to in paragraph 1(b) and all formulators of biocidal products containing that active substance may start or continue to place on the market the active substance, as such or in biocidal products, in the product type or types for which the Commission has accepted at least one notification.
In accordance with the procedure laid down in Article 28(3) of the Directive, Decisions addressed to Member States shall be adopted stating that the following active substances shall not be included in Annex I, Annex IA or Annex IB to the Directive under the review programme and that these active substances, solely or in biocidal products, shall no longer be placed on the market for biocidal purposes:
active substances not included in the list referred to in paragraph 1(b);
active substances included in the list referred to in paragraph 1(b) in product types for which the Commission has not accepted at least one notification.
However if the active substance is included in the list of existing active substances referred to in paragraph 1(a), a reasonable phase-out period shall be allowed of not more than three years from the date on which the Decision referred to in the first subparagraph takes effect.
The following applications for inclusion of existing active substances in Annex I, Annex IA or Annex IB to the Directive shall be treated as if the substance was not placed on the market for use in biocidal products before 14 May 2000:
an application for inclusion of an active substance not included in the list referred to in paragraph 1(b);
an application for inclusion of an active substance in product types other than those for which it is included in the list referred to in paragraph 1(b).
—————